Biotech

All Articles

Editas cashes in on Vertex Cas9 licensing civil liberties for $57M

.Versus the backdrop of a Cas9 patent struggle that declines to pass away, Editas Medicine is moneyi...

Ultragenyx fine-tunes genetics treatment dosing to call up efficacy

.A minority of clients taking Ultragenyx Pharmaceutical's Wilson illness genetics treatment UX701 ha...

Biopharma cutback price maintains in Q3: Brutal Biotech review

.As summer heat looks to cool down winds, hopes that this year would deliver widespread market allev...

J &amp J falls stage 2 dengue prospect in newest change from vaccinations

.Johnson &amp Johnson's deprioritization of its contagious ailment pipe has professed another victim...

Relay sheds 10% of personnel after earlier unemployments in July

.Accuracy medicine biotech Relay Rehabs is dropping about 10% of its own staff in initiatives to str...

Pentixapharm ratings $22M IPO to loan radiopharma tests

.Pentixapharm has actually introduced virtually twenty million europeans ($ 22 million) coming from ...

Lundbeck taps Charles River for AI-enabled neuro medicine invention

.Lundbeck has utilized Charles Waterway Laboratories' expert system abilities to help the discovery ...

Big pharma, biotech 'won't necessarily be symbiotic' in artificial intelligence: S&ampP

.Large Pharma is actually committing intensely in artificial intelligence to slash development timel...

I &amp I biotech Triveni elevates $115M for preclinical antibodies

.Triveni Bio has trapped $115 thousand in collection B funds to progress preclinical antitoxin plans...

IGM pivots coming from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences ended in 2015 giving up workers as well as improving its cancer cells pipeline. Rig...